Table IV.
Relationship between serum vitamin D/cyp24a expression by PBMC and vitamin D/corticosteroid response markers in asthmatic children
| Predictor | Outcome | Asthma, children | ||
|---|---|---|---|---|
| 6–12yrs, n=37 | 13–17yrs, n=16 | |||
| Rsq | p value | p value | ||
| Serum vitamin D, ng/ml | Log serum LL-37, pg/ml | 0.39 | 0.006 | 0.10 |
| cyp24a expression by PBMC (ng cyp24a/ng 18s RNA) | 0.23 | 0.016 | 0.86 | |
| IgE, U/ml | 0.21 | 0.023 | 0.056 | |
| ICS dose, μg | 0.11 | 0.72 | ||
| cyp24a expression by PBMC (ng cyp24a/ng 18s RNA) | ICS dose, μg | 0.067 | 0.21 | |
| TNFα fold suppression by DEX in PBMC | 0.069 | 0.28 | ||
| IL-13 fold suppression by DEX in PBMC | 0.13 | 0.052 | ||